141 related articles for article (PubMed ID: 35137416)
21. The potential mechanisms and treatment effects of stem cell-derived exosomes in cardiac reengineering.
Wang Y; Shi X
Nanotechnology; 2024 Jun; 35(36):. PubMed ID: 38834043
[TBL] [Abstract][Full Text] [Related]
22. The Roles of Exosomal Proteins: Classification, Function, and Applications.
Li XX; Yang LX; Wang C; Li H; Shi DS; Wang J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834471
[TBL] [Abstract][Full Text] [Related]
23. Research Progress of Exosomal microRNA in Cardiovascular Disease and Its Forensic Application Prospects.
Ma XN; Lu L; Huang YT; Cen CQ; Su FY; Shi Y; Cao ZP
Fa Yi Xue Za Zhi; 2022 Apr; 38(2):258-262. PubMed ID: 35899516
[TBL] [Abstract][Full Text] [Related]
24. Exosomes in chronic liver disease.
Basthi Mohan P; Rajpurohit S; Musunuri B; Bhat G; Lochan R; Shetty S
Clin Chim Acta; 2023 Feb; 540():117215. PubMed ID: 36603656
[TBL] [Abstract][Full Text] [Related]
25. Exosomes: New Insights into the Pathogenesis of Metabolic Syndrome.
Wang N; Li J; Hu Z; Ngowi EE; Yan B; Qiao A
Biology (Basel); 2023 Dec; 12(12):. PubMed ID: 38132306
[TBL] [Abstract][Full Text] [Related]
26. Exosomal microRNA-Based therapies for skin diseases.
Jibing C; Weiping L; Yuwei Y; Bingzheng F; Zhiran X
Regen Ther; 2024 Mar; 25():101-112. PubMed ID: 38178928
[TBL] [Abstract][Full Text] [Related]
27. A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose.
Jiang W; Jin Q; Li C; Xun Y
Turk J Gastroenterol; 2023 Nov; ():. PubMed ID: 37966266
[TBL] [Abstract][Full Text] [Related]
28. Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs.
Thibonnier M; Ghosh S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108289
[TBL] [Abstract][Full Text] [Related]
29. The Role of Extracellular Vesicles in Metabolic Diseases.
González-Blanco C; Iglesias-Fortes S; Lockwood ÁC; Figaredo C; Vitulli D; Guillén C
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790954
[TBL] [Abstract][Full Text] [Related]
30. Correction to: Exosomal MicroRNAs: Comprehensive Methods from Exosome Isolation to miRNA Extraction and Purity Analysis.
D'Agostino E; Muro A; Sgueglia G; Massaro C; Dell'Aversana C; Altucci L
Methods Mol Biol; 2023; 2595():C1. PubMed ID: 36708460
[No Abstract] [Full Text] [Related]
31. miRNA-205: a future therapeutic molecule for liver diseases.
Cabrera M; Kolli M; Jaggi M; Chauhan SC; Yallapu MM
Future Drug Discov; 2023 Jan; 4(3):FDD78. PubMed ID: 36908931
[No Abstract] [Full Text] [Related]
32. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
Hochreuter MY; Dall M; Treebak JT; Barrès R
Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
[TBL] [Abstract][Full Text] [Related]
33. Circulating miRNAs associated with nonalcoholic fatty liver disease.
Atic AI; Thiele M; Munk A; Dalgaard LT
Am J Physiol Cell Physiol; 2023 Feb; 324(2):C588-C602. PubMed ID: 36645666
[TBL] [Abstract][Full Text] [Related]
34. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).
Qi X; Lai J
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362287
[TBL] [Abstract][Full Text] [Related]
35. MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH.
Gao H; Jin Z; Bandyopadhyay G; Cunha E Rocha K; Liu X; Zhao H; Zhang D; Jouihan H; Pourshahian S; Kisseleva T; Brenner DA; Ying W; Olefsky JM
Cell Metab; 2022 Jul; 34(7):978-990.e4. PubMed ID: 35700738
[TBL] [Abstract][Full Text] [Related]
36. Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients.
Ng L; Sin RW; Cheung DH; Leung WK; Man AT; Lo OS; Law WL; Foo DC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240431
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of engineered exosomes in nonalcoholic fatty liver disease.
Ding J; Xu C; Xu M; He XY; Li WN; He F
World J Hepatol; 2023 Mar; 15(3):386-392. PubMed ID: 37034232
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases.
Yin KL; Li M; Song PP; Duan YX; Ye WT; Tang W; Kokudo N; Gao Q; Liao R
J Clin Transl Hepatol; 2023 Apr; 11(2):441-451. PubMed ID: 36643031
[TBL] [Abstract][Full Text] [Related]
39. Adipocytes-derived exosomal miR-122 promotes non-alcoholic fat liver disease progression via targeting Sirt1.
Chen K; Lin T; Yao W; Chen X; Xiong X; Huang Z
Gastroenterol Hepatol; 2023; 46(7):531-541. PubMed ID: 36584755
[TBL] [Abstract][Full Text] [Related]
40. M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model.
Wan Z; Yang X; Liu X; Sun Y; Yu P; Xu F; Deng H
iScience; 2022 Jul; 25(7):104597. PubMed ID: 35789846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
